Published On: 26 January 2024Tags: ,

The NHS has launched a groundbreaking test to make blood transfusions safer and more personalised. This is exciting news for thousands of people in England dealing with sickle cell disorder and thalassaemia. The NHS is the first in the world to offer this unique blood matching test.

Around 18,000 people in England can benefit from this test, which checks the genes in your blood to find a better match for transfusions. This helps avoid problems and makes sure patients get the right blood they need. The NHS is also testing donor blood to make sure it matches well.

This is a game-changer for patients. Many face issues after transfusions, like delays in treatment or bad reactions. With this new test, the NHS aims to reduce these problems and make sure people get the right care.

Patients with sickle cell disorder and thalassaemia, along with those with transfusion-dependent rare inherited anaemias, like Diamond Blackfan anaemia, are encouraged to take this test during their routine hospital visits. It’s a simple way to improve treatment.

In England, about 17,000 people have sickle cell disorder, causing pain and organ damage. Thalassaemia, affecting around 800 people, stops the body from making enough oxygen-carrying haemoglobin and can be fatal if not treated. This new test is a step forward in caring for these conditions and making sure patients get the best treatment possible.